BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28127670)

  • 1. Cervical cancer screening for survivors diagnosed with cancer before age 25.
    Tseng OL; Spinelli JJ; Dawes M; McBride ML
    J Cancer Surviv; 2017 Jun; 11(3):410-419. PubMed ID: 28127670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of papanicolaou (Pap) test rates across Ontario and factors associated with cervical screening.
    Fehringer G; Howlett R; Cotterchio M; Klar N; Majpruz-Moat V; Mai V
    Can J Public Health; 2005; 96(2):140-4. PubMed ID: 15850036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer incidence in British Columbia: Predicting effects of changes from Pap to human papillomavirus screening and of changes in screening participation.
    Coldman A; van Niekerk D; Smith L; Ogilvie G
    J Med Screen; 2017 Dec; 24(4):195-200. PubMed ID: 27810984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
    Abdul Rashid RM; Dahlui M
    Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with underscreening for cervical cancer among women in Canada.
    Schoueri-Mychasiw N; McDonald PW
    Asian Pac J Cancer Prev; 2013; 14(11):6445-50. PubMed ID: 24377548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's Behaviors Toward Mammogram and Pap Test: Opportunities to Increase Cervical Cancer Screening Participation Rates among Older Women.
    Tavasoli SM; Kane E; Chiarelli AM; Kupets R
    Womens Health Issues; 2018; 28(1):42-50. PubMed ID: 29174212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pap tests in the diagnosis of cervical cancer: Help or hinder?
    Philp L; Jembere N; Wang L; Gao J; Maguire B; Kupets R
    Gynecol Oncol; 2018 Jul; 150(1):61-66. PubMed ID: 29773301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000-2011).
    Whop LJ; Garvey G; Baade P; Cunningham J; Lokuge K; Brotherton JM; Valery PC; O'Connell DL; Canfell K; Diaz A; Roder D; Gertig D; Moore SP; Condon JR
    Cancer; 2016 May; 122(10):1560-9. PubMed ID: 27149550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Community-Academic Partnership to Increase Pap Testing in Appalachian Kentucky.
    Collins T; Stradtman LR; Vanderpool RC; Neace DR; Cooper KD
    Am J Prev Med; 2015 Aug; 49(2):324-30. PubMed ID: 26190807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
    Miller RA; Mody DR; Tams KC; Thrall MJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Cervical Smears Performed by General Practitioners on the Cervical Cancer Screening Rate of their Female Patients: A Claim Database Analysis and Cross-Sectional Survey.
    Favre J; Rochoy M; Raginel T; Pelletier M; Messaadi N; Deken-Delannoy V; Duhamel A; Berkhout C
    J Womens Health (Larchmt); 2018 Jul; 27(7):933-938. PubMed ID: 29583084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.
    White MC; Shoemaker ML; Benard VB
    Am J Prev Med; 2017 Sep; 53(3):392-395. PubMed ID: 28473240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of invitation and reminder letters on cervical cancer screening participation rates in an organized screening program.
    Tavasoli SM; Pefoyo AJ; Hader J; Lee A; Kupets R
    Prev Med; 2016 Jul; 88():230-6. PubMed ID: 27143497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening in Korea: report on the National Cancer Screening Programme in 2008.
    Mun JY; Han MA; Lee HY; Jun JK; Choi KS; Park EC
    Asian Pac J Cancer Prev; 2011; 12(8):1961-4. PubMed ID: 22292633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of Cervical Cancer Screening Uptake in Kurdish Women Living in Western Iran, 2014.
    Aminisani N; Fattahpour R; Abedi L; Shamshirgaran SM
    Asian Pac J Cancer Prev; 2016; 17(8):3763-7. PubMed ID: 27644614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of bone mineral density testing among breast cancer survivors in British Columbia, Canada.
    Tseng OL; Dawes MG; Spinelli JJ; Gotay CC; McBride ML
    Osteoporos Int; 2017 Dec; 28(12):3439-3449. PubMed ID: 28993862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of cervical cancer screening rates among women with traumatic spinal cord injury and the general population.
    Guilcher SJ; Newman A; Jaglal SB
    J Womens Health (Larchmt); 2010 Jan; 19(1):57-63. PubMed ID: 20088659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.